Skip to main content
HR 5377 117th Congress House Health Cancer Health care costs and insurance Health care coverage and access Health promotion and preventive care Medicaid Medical tests and diagnostic methods Medicare Poverty and welfare assistance State and local government operations

Cancer Patient Equity Act of 2021

Introduced: September 27, 2021 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 28, 2021
Referred to the Subcommittee on Health.
Sep 27, 2021
Referred to the Subcommittee on Health.
Sep 27, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 27, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Cancer Patient Equity Act of 2021

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

What's happening now September 28, 2021

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Lobbying activity 1

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

 Cosponsors 16
All 16 Democratic 8 Republican 6
D
Wasserman Schultz, Debbie
Florida · Sep 28, 2022
 D
Aguilar, Pete
California · Jun 28, 2022
 D
Veasey, Marc A.
Texas · May 3, 2022
 D
Neguse, Joe
Colorado · Feb 28, 2022
 D
DeSaulnier, Mark
California · Feb 22, 2022
Lamb, Conor
· Feb 1, 2022
 D
Auchincloss, Jake
Massachusetts · Jan 18, 2022
 D
Trahan, Lori
Massachusetts · Jan 18, 2022
 R
Hern, Kevin
Oklahoma · Jan 6, 2022
DOYLE, MIKE
· Jan 3, 2022
 D
Titus, Dina
Nevada · Dec 23, 2021
 R
Bacon, Don
Nebraska · Dec 2, 2021
 R
Fleischmann, Charles J. "Chuck"
Tennessee · Dec 2, 2021
 R
Fitzpatrick, Brian K.
Pennsylvania · Nov 23, 2021
 R
Barr, Andy
Kentucky · Oct 15, 2021
 R
Bilirakis, Gus M.
Florida · Sep 27, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5377: Cancer Patient Equity Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-5377/
MLA
"H.R. 5377: Cancer Patient Equity Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-5377/.
Bluebook (legal)
H.R. 5377, 117th Cong. (2026), https://openamerica.io/bill/117-HR-5377/.
Markdown link
[H.R. 5377: Cancer Patient Equity Act of 2021](https://openamerica.io/bill/117-HR-5377/)
Report a problem